CDEK by Data4ThePeople

Sign in Sign up

← All organizations

Tolero Pharmaceuticals

For profitWebsite ↗

Also known as: Tolero Pharmaceuticals | Tolero Pharmaceuticals, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Jul 31, 2020

Acquired by Sumitomo Dainippon on Jun 1, 2017

Timeline

2010s

Jan 1, 2011
Tolero Pharmaceuticals— Founded
Jun 1, 2017
Sumitomo Dainippon— Acquired By

Drugs by trial phase (14 distinct, 11 trials)

Phase 2 (6 own, 0 via acquisition)

Phase 1 (8 own, 0 via acquisition)

Indications

Studied for

Recent trials (21)

NCT04328740Lead sponsorPhase 1Jul 31, 2020
NCT04328740Study directorPhase 1Jul 31, 2020
NCT03969420Lead sponsorPhase 2Sep 30, 2019
NCT03969420Study directorPhase 2Sep 30, 2019
NCT03715504Lead sponsorPhase 1Apr 16, 2019
NCT03715504Study directorPhase 1Apr 16, 2019
NCT03593915Study directorPhase 1/Phase 2Sep 30, 2018
NCT03593915Lead sponsorPhase 1/Phase 2Sep 30, 2018
NCT03572634Study directorPhase 1/Phase 2Sep 30, 2018
NCT03572634Lead sponsorPhase 1/Phase 2Sep 30, 2018
NCT03604783Study directorPhase 1Aug 31, 2018
NCT03604783Lead sponsorPhase 1Aug 31, 2018
NCT03441555CollaboratorPhase 1May 30, 2018
NCT03429218Study directorPhase 1Mar 31, 2018
NCT03429218Lead sponsorPhase 1Mar 31, 2018

Details

Founded: Lehi, UT, US Jan 1, 2011
Last known activity: Jul 31, 2020